Protein Delivery and Mimicry
Publisher
Springer Singapore
Reference268 articles.
1. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., et al. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science, 298, 846–850. 2. Abu-Awwad, H. A. M., Thiagarajan, L., & Dixon, J. E. (2017). Controlled release of GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery. Acta Biomaterialia, 57, 225–237. 3. Acar, H., Ting, J. M., Srivastava, S., Labelle, J. L., & Tirrell, M. V. (2017). Molecular engineering solutions for therapeutic peptide delivery. Chemical Society Reviews. 4. Ahmed, C. M., Massengill, M. T., Brown, E. E., Ildefonso, C. J., Johnson, H. M., & Lewin, A. S. (2018). A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis. Experimental Eye Research, 177, 12–22. 5. Akishiba, M., Takeuchi, T., Kawaguchi, Y., Sakamoto, K., Yu, H. H., Nakase, I., et al. (2017). Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nature Chemistry, 9, 751–761.
|
|